RESOURCE / PUBLIC SOURCE RECORD
UK Digital Health Advisory Panel 2026
- Three-part webinar/advisory programme ran 13 February–5 June 2026, sessions 12:00–14:00 Norwegian time. Innovation Norway described it as expert support for Norwegian companies developing UK-market growth strategies. Intended for Norwegian health and life-science exporters seeking UK/Ireland partnerships; participants were expected to attend all three meetings. Company places were limited, registration was by expression of interest, and individual follow-up with advisors between sessions was at the companies’ own expense. No programme fee was listed.
- Webinar 1, “Market Entry and Qualification” (13 February): Jason Leitch CBE (professor, patient-safety/healthcare-quality expert, IHI Senior Fellow, former Scotland National Clinical Director); Nicola Haywood-Cleverly (non-executive director, strategic advisor and transformation lead); Michelle Tempest (doctor, board member, investor, advisor, author and Candesic partner); Rhidian Hurle (Chief Clinical Information Officer, Wales; Medical Director, Digital Health and Care Wales; part-time consultant urological surgeon; professor at UWTSD).
- Webinar 2, “Advancing Early Interest and Securing the Offer” (17 April): Tony Bowden (CEO, Helicon Health); Peter Gerber (healthcare consultant); Conor Burke (CEO, UHUK; non-executive director/advisor).
- Webinar 3, “Business Case and Procurement Readiness” (5 June): Kamal Lakhpuri (Director of Digital Informatics, East Genomic Medicine Service Alliance, and global digital-health project assurance/coordinator); Martin Bell (healthcare, IT and business consultant); Thomas Webb (NHS digital leader, founder/former CEO, non-executive director and EPR usability specialist).
- Across the three meetings, companies were to develop a strategy, growth plan or business case; get advisor feedback; exchange lessons with Norwegian peers; and pitch their plan for feedback at the end. Panel objectives included specialist expertise, anticipating market changes, stakeholder connections and strategic support for innovation/growth. Contacts: Maren Jervell Lund, Senior Advisor & TEA Programme, UK and Ireland (maren.jervell.lund@innovationnorway.no; +44 (0) 7741892217; LinkedIn: linkedin.com/in/maren-jervell-lund/); Tone Varslot Stave, Head of national export initiative on health and life science, Innovation Norway (tone.varslot.stave@innovasjonnorge.no; +47 952 25 533). Responsible-business/ESG and due-diligence conditions applied.